Bro's VerdictDeep Dive
Rating
BUY
Confidence
62%
Target Price
A$5.88
Upside
+60.7%
Horizon
medium
MGH has de-rated ~50% from highs on the pulled Firmus IPO, yet consensus still models 20.3% EPS growth and 24.1% EBIT growth, leaving the stock at 15.4x NTM P/E and ~12.9x EV/EBIT, toward the lower end of its peer band. The consensus target of $5.88 and fair value range of $4.80-$5.90 imply 31-61% upside, but leverage, weak cash conversion and disclosure concerns warrant only moderate confidence. The risk/reward skews positive for a patient investor contingent on a constructive Firmus resolution and evidence that EBITDA growth converts to cash.
Executive Summary
Financial Snapshot
Forward Outlook
Valuation Analysis
Peer Comparison (indicative Australian civil and infrastructure services)
Key Risks & Catalysts
Risks
Catalysts
Investment Thesis
MGH is an integrated civil, hire and manufacturing platform caught in a sentiment storm rather than an earnings downgrade. The Firmus IPO collapse triggered a 22% single day fall and a ~50% drawdown from highs, yet consensus still models 20.3% EPS growth, 24.1% EBIT growth and 33.6% EBITDA growth. At $3.66, the stock trades at 15.4x NTM P/E and roughly 12.9x NTM EV/EBIT, a discount to its own EV/EBIT history and toward the lower end of the Australian civil services peer band despite superior growth. The P/BV of 1.3x against a 5.4x two year average is the most striking dislocation, though it is likely distorted by balance sheet changes and should be treated cautiously.
The counterweight is real. Leverage at 118.8% D/E, net debt of $653.5m and free cash flow growth of just 1.6% mean the equity is sensitive to any execution slip, and the inconsistent disclosure across data sources is a genuine governance flag. The stock is also technically broken, sitting below every key moving average with negative momentum.
Net, the risk reward skews positive for a patient investor. Fair value range of $4.80 to $5.90, anchored on own history EV/EBIT reversion ($4.81) and the consensus target ($5.88), implies 31% to 61% upside. The thesis is contingent on two things: the Firmus situation being resolved constructively, and the next result confirming that EBITDA growth converts into cash. Accumulate on weakness toward $3.20 to $3.40 with a stop below the 52 week low of $3.21, sizing for the leverage and disclosure risk.